Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy-Reference-Cited by-同舟云学术

Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

Published:2013 Issue: Volume:2013 Page:1-3
ISSN:2090-6706
Container-title:Case Reports in Oncological Medicine
language:en
Short-container-title:Case Reports in Oncological Medicine

Author:

Porcello Marrone Luiz Carlos¹,Marrone Bianca Fontana¹,Pascoal Tharick Ali¹,Schilling Lucas Porcello¹,Soder Ricardo Bernardi¹,Ferreira Sheila Schuch¹,Gadonski Giovani¹,da Costa Jaderson Costa¹

Affiliation:

1. Hospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, Brazil

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.

Publisher

Hindawi Limited

Subject

Oncology

Link

http://downloads.hindawi.com/journals/crionm/2013/306983.pdf

Reference10 articles.

1. A Reversible Posterior Leukoencephalopathy Syndrome

2. Parietal Occipital Edema in Hypertensive Encephalopathy: A Pathogenic Mechanism

3. Hypertensive Encephalopathy

4. Diffusion-Weighted Imaging Discriminates Between Cytotoxic and Vasogenic Edema in a Patient With Eclampsia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Acute Encephalopathy After the Initiation of FOLFOX Chemotherapy in a Patient With Colon Cancer;Cureus;2023-04-07

2. Central Nervous System Complications Among Oncology Patients;Hematology/Oncology Clinics of North America;2022-02

3. Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy;Frontiers in Neurology;2020-01-30

4. Chemotherapy induced stroke mimic: 5-Fluorouracil encephalopathy fulfilling criteria for tissue plasminogen activator therapy;The American Journal of Emergency Medicine;2017-09

5. Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device;Frontiers in Neurology;2016-11-07